| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.08 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.072 | 0.08 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.08 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.08 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.48 | 0.08 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.08 |